Hydrochlorothiazide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Hydrochlorothiazide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

HYDROCHLOROTHIAZIDE DESCRIPTION


Hydrochlorothiazide








CLINICAL PHARMACOLOGY



PHARMACOKINETICS





PHARMACODYNAMICS




CLINICAL STUDIES



INDICATIONS & USAGE





HYDROCHLOROTHIAZIDE CONTRAINDICATIONS



WARNINGS





PRECAUTIONS











DRUG INTERACTIONS












DRUG & OR LABORATORY TEST INTERACTIONS

PRECAUTIONS, General

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY




PREGNANCY

Teratogenic Effects:




Nonteratogenic Effects:


NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE



HYDROCHLOROTHIAZIDE ADVERSE REACTIONS







PRECAUTIONS


WARNINGS





OVERDOSAGE





DOSAGE & ADMINISTRATION



HOW SUPPLIED


























INACTIVE INGREDIENT

D&C RED NO. 28
D&C YELLOW NO. 10
FD&C BLUE NO. 1
FERRIC OXIDE BLACK
GELATIN
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
COLLOIDAL SILICON DIOXIDE
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STARCH, CORN
TITANIUM DIOXIDE

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Hydrochlorothiazide





Hydrochlorothiazide



Hydrochlorothiazide

Hydrochlorothiazide CAPSULE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-681(NDC:23155-140)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 12.5 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
STARCH, CORN
SODIUM STARCH GLYCOLATE TYPE A POTATO
SILICON DIOXIDE
MAGNESIUM STEARATE
GELATIN
FD&C BLUE NO. 1
D&C RED NO. 28
D&C YELLOW NO. 10
titanium dioxide
SODIUM LAURYL SULFATE
FERROSOFERRIC OXIDE

Product Characteristics

Color Size Imprint Code Shape
turquoise 15 mm RF26 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-681-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079237 2011-05-13


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.